Andrew Jennings

Andrew Jennings is a seasoned finance professional with extensive experience in financial leadership roles across various pharmaceutical companies. Currently serving as Senior Director of Commercial Finance at NewAmsterdam Pharma Corporation since May 2024, Andrew oversees financial management and strategy execution. Previous positions include Director of Financial Planning and Analysis at Zynerba Pharmaceuticals, where responsibilities encompassed long-range financial projections and internal reporting, and Corporate Controller & Director of Financial Reporting at Egalet Corporation, managing global accounting and monthly close activities. Andrew's early career includes roles at ViroPharma Incorporated, Endo Pharmaceuticals Inc., and KPMG Audit, where essential skills in forecasting, budgeting, and audit management were developed. Educationally, Andrew holds a B.S. in Accounting from Lehigh University.